The bio sector is littered with Phase 1, 2 & 3 trials where companies have spent millions of $ and failed to take the product to the next stage or commercialised.
Just because we have Professor Fraser and his team working on this guarantees nothing and they might have a far greater understanding of how they expect the vac to work, but they don't know the results until they are released to them.
I think AHZ has amazing products but let's keep it real, getting the vac to market is still a long shot. For me that's the chance of blue sky but I'm here for adapt.
The bio sector is littered with Phase 1, 2 & 3 trials where...
-
- There are more pages in this discussion • 93 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$13.14 |
Change
0.000(0.00%) |
Mkt cap ! $277.7M | |||
| Open | High | Low | Value | Volume |
| $13.33 | $13.91 | $13.14 | $302.2K | 22.46K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 299 | $13.14 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.49 | 35 | 1 |
View Market Depth
| Last trade - 16.10pm 13/09/2024 (20 minute delay) ? |
| AVR (ASX) Chart |